Finanzwire Finanzwire
Basculer en Français
10184 Companies
209529 Keywords
139629 Articles
111067 Press releases
Headlines Articles Press releases POP Biotechnologies, Inc. Remove
  1. Home
  2. Companies
  3. POP Biotechnologies, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/27/2024 at 20:05, 1 year 6 months ago

    POP Biotechnologies Announces Positive Interim Results for COVID-19 Vaccine Trial

    COVID-19 Vaccine Phase 3 Trial Immunogenicity EuCorVac-19 POP BIO SNAP
  • PRESS RELEASE

    published on 09/27/2024 at 20:00, 1 year 6 months ago

    POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

    POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant
    COVID-19 Vaccine Phase 3 Trial POP Biotechnologies EuBiologics ECV-19
    Logo of POP Biotechnologies, Inc.
  • PRESS RELEASE

    published on 07/14/2023 at 18:00, 2 years 8 months ago

    POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    Logo of POP Biotechnologies, Inc.
Accesswire
  • Published on 04/09/2026 at 16:00, 59 minutes ago

    Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X

  • Published on 04/09/2026 at 14:40, 2 hours 19 minutes ago

    Silver X Delivers Production Growth During the First Quarter of 2026

  • Published on 04/09/2026 at 14:00, 2 hours 59 minutes ago

    Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

  • Published on 04/09/2026 at 13:30, 3 hours 29 minutes ago

    Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Published on 04/09/2026 at 13:30, 3 hours 29 minutes ago

    ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE
EQS Group
  • Published on 04/09/2026 at 15:59, 59 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:57, 1 hour 2 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:40, 1 hour 19 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 04/09/2026 at 15:39, 1 hour 19 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 04/09/2026 at 15:39, 1 hour 20 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

View all EQS
Les Echos
  • Published on 04/09/2026 at 15:57, 1 hour 1 minute ago

    Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports

  • Published on 04/09/2026 at 07:00, 9 hours 59 minutes ago

    bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  • Published on 04/08/2026 at 18:02, 22 hours 57 minutes ago

    Publication of the 2025 Universal Registration Document

  • Published on 04/08/2026 at 17:45, 23 hours 14 minutes ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 04/08/2026 at 12:58, 1 day 4 hours ago

    EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy